Douglas Mental Health University Institute
40
10
13
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
2.5%
1 terminated/withdrawn out of 40 trials
95.0%
+8.5% vs industry average
3%
1 trials in Phase 3/4
11%
2 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (40)
Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia
Role: collaborator
Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia
Role: lead
The Acceptability and Effectiveness of Receiving a Low-intensity Self-guided Psychoeducational Intervention for Individuals Waitlisted for Specialized Eating-disorder Treatment
Role: lead
Daridorexant for Alzheimer Disease Prevention
Role: lead
Spatial Memory Training and Cognitive Function
Role: lead
Intergenerational Behavioral Intervention to Enhance Physical Activity in Older Adults at Risk for Alzheimer's Disease
Role: lead
Online MBCT vs HEP for Depressive Symptoms in Older Adults: RCT
Role: collaborator
HYEEG Discourse in Psychosis: A Neurobehavioural Study
Role: lead
Magnetoencephalography in Psychosis Program
Role: lead
Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories
Role: lead
DIALOG: Understanding Disorganisation: A Language-focused Global Initiative in Psychosis
Role: lead
Predicting Psychotic Relapse Using Speech-Based Early Detection
Role: lead
Virtual Travel Into Nature for Individuals With Lived Experience of Severe Mental Disorders
Role: lead
VR-CBT With Inuit in Quebec
Role: lead
Promoting Cognitive Health in Schizophrenia
Role: lead
Cognitive Remediation for Social Cognition in Schizophrenia and Related Disorders
Role: lead
Exogenous Melatonin in Postmenopausal Women with Insomnia
Role: lead
Social Skills and Emotion Regulation Training "SSERT" for Trauma in Psychosis
Role: lead
Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression
Role: lead
Brexpiprazole Treatment for Bipolar I Depression
Role: lead